Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6599)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 26, 2021 (publication date) through Feb 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu YQ, Long X, Han M, Huang MQ, Lu JF, Sun XD, Han W. Clinical benefit of COX-2 inhibitors in the adjuvant chemotherapy of advanced non-small cell lung cancer: A systematic review and meta-analysis. World J Clin Cases 2021; 9(3): 581-601 [PMID: 33553396 DOI: 10.12998/wjcc.v9.i3.581] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i3/581.htm |
| Number | Citing Articles |
| 1 |
Pengfei Xin, Shirui Wang, Xin Xu, Qingmei Liu, Caifeng Zhang. Natural fulvic acids inhibit non-small-cell lung cancer through the COX-2/PGE2/EP4 axis: In silico and in vivo assessments. Heliyon 2023; 9(6): e17080 doi: 10.1016/j.heliyon.2023.e17080
|
| 2 |
Jan Korbecki, Donata Simińska, Magdalena Gąssowska-Dobrowolska, Joanna Listos, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka. Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms. International Journal of Molecular Sciences 2021; 22(19): 10701 doi: 10.3390/ijms221910701
|
| 3 |
Pavel Jakoube, Valentina Cutano, Juan M. González-Morena, Zuzana Keckesova. Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression. Cancer Research 2021; 81(18): 4652 doi: 10.1158/0008-5472.CAN-21-0518
|
| 4 |
Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul, Marc-Eric Halatsch. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers 2022; 14(10): 2563 doi: 10.3390/cancers14102563
|